| Literature DB >> 34731301 |
Dirk R Bulian1, Sebastian Walper2, Dana C Richards2, Sissy-A Schulz2, Claudia S Seefeldt2, Panagiotis Thomaidis2, Jurgen Meyer-Zillekens2, Markus M Heiss2.
Abstract
PURPOSE: Even though obesity is a known risk factor for needing cholecystectomy, most research excludes patients with higher degrees of obesity. The aim of this retrospective study was to compare postoperative pain and analgesic consumption in obese patients, who underwent either transvaginal hybrid Natural Orifice Transluminal Endoscopic Surgery (NOTES) cholecystectomy (NC) or traditional laparoscopic cholecystectomy (LC).Entities:
Keywords: Body mass index; Cholecystectomy; Obesity; Outcome; Pain; Transvaginal NOTES
Mesh:
Year: 2021 PMID: 34731301 PMCID: PMC9160114 DOI: 10.1007/s00464-021-08855-7
Source DB: PubMed Journal: Surg Endosc ISSN: 0930-2794 Impact factor: 3.453
Fig. 1Trial flow diagram
Baseline characteristics of all patients
| Variable | NC ( | LC ( | Total ( | |
|---|---|---|---|---|
| Age [years] | 43.0 (25–63) | 45.0 (25–72) | 43.5 (25–72) | 0.182 |
| Height [cm] | 165 (150–184) | 167 (155–179) | 166.5 (150–184) | 0.874 |
| Weight [kg] | 112 (80–171) | 111 (85–150) | 112 (80–171) | 0.613 |
| BMI [kg/m2] | 40.6 (35.3–57.8) | 41.2 (35.4–54.7) | 40.8 (35.3–57.8) | 0.553 |
| Indication | 0.459 | |||
| Symptomatic cholecystolithiasis | 33 (94.3) | 29 (82.9) | 62 (88.6) | |
| Cholecystitis | 1 (2.9) | 3 (8.6) | 4 (5.7) | |
| Choledocholithiasis | 1 (2.9) | 2 (5.7) | 3 (4.3) | |
| Biliary pancreatitis | 0 (0) | 1 (2.9) | 1 (1.4) | |
| ASA | 0.611 | |||
| 1 | 0 (0) | 0 (0) | 0 (0) | |
| 2 | 13 (28.6) | 10 (37.1) | 23 (32.9) | |
| 3 | 22 (71.4) | 25 (62.9) | 47 (67.1) | |
| History of major abdominal surgery | 1.000 | |||
| Yes | 5 (14.3) | 6 (17.1) | 11 (15.7) | |
| No | 30 (85.7) | 29 (82.9) | 59 (84.3) | |
| Preoperative pain [NRS] | 0.741 | |||
| 0 | 31 (88.6) | 31 (88.6) | 62 (88.6) | |
| 1 | 1 (2.9) | 0 (0) | 1 (1.4) | |
| 2 | 1 (2.9) | 2 (5.7) | 3 (4.3) | |
| 3 | 1 (2.9) | 2 (5.7) | 3 (4.3) | |
| 7 | 1 (2.9) | 0 (0) | 1 (1.4) | |
| Need of preoperative analgesics | 1.000 | |||
| Yes | 4 (11.4) | 4 (11.4) | 8 (11.4) | |
| No | 31 (88.6) | 31 (88.6) | 62 (88.6) |
Values are reported as median (min–max) and counts (percentage)
NC transvaginal hybrid NOTES cholecystectomy, LC traditional 4-trocar laparoscopic cholecystectomy, BMI Body Mass Index, NRS Numeric Rating Scale, ASA American Society for Anesthesiologists
Fig. 2Daily intensity of pain
Fig. 3Cumulative pain
Fig. 4Daily use of paracetamol
Fig. 5Daily use of piritramide
Patient outcome
| Variable | NC ( | LC ( | Total ( | |
|---|---|---|---|---|
| Procedural time [min] | 68 (31)* | 70 (29)* | 69 (29)* | 0.643 |
| Demand medication requested | 9 (25.7)** | 13 (37.1)** | 22 (31.4)** | 0.440 |
| Cumulative paracetamol, from DOS to POD 2 [mg] | 6,500 (0)* | 9,000 (5,000)* | 6,500 (3125)* | 0.005 |
| Cumulative piritramide, from DOS to POD 2 [mg] | 1.5 (7.5)* | 5.0 (27.0)* | 4.5 (15.0)* | 0.047 |
| Postoperative complications | 1 (2.9)** | 5 (14.3)** | 6 (8.6)** | 0.198 |
| Clavien–Dindo classification of postoperative complications | 0.198 | |||
| No complication | 34 (97.1)** | 30 (85.7)** | 64 (91.4)** | |
| Grade I | 1 (2.9)** | 5 (14.3)** | 6 (8.6)** | |
| Grades II to V | 0 (0)** | 0 (0)** | 0 (0)** | |
| Postoperative hospital stay [days] | 2 (0)* | 3 (1)* | 2 (1)* | < 0.001 |
| Mortality | 0** | 0** | 0** |
Values are reported as median (interquartile range)* and counts (percentage)**
NC transvaginal hybrid NOTES cholecystectomy, LC traditional 4-trocar laparoscopic cholecystectomy, DOS day of surgery, POD postoperative day